Virbac United States Introduces URSOLYX™ Soft Chews: Innovation in Canine Muscle Health
Virbac, a global leader in animal health, has collaborated with Emmyon, Inc., a biotechnology company specializing in skeletal muscle biology, to introduce URSOLYX™ Soft Chews. This first-in-itsclass muscle support product features ursolic acid, which targets mRNA expression in skeletal muscle.
Virbac Offers New BRD Vaccine With Three Extra Layers of Protection
BOVIGEN® Platinum Synvera, a new combination vaccine, adds Mannheimia haemolytica genotypes 1 and 2, and Pasteurella multocida protection to 5-way BRD modified-live vaccine.
Virbac and Senior Dog Veterinary Society Announcement
Virbac and Senior Dog Veterinary Society announce collaboration to advance senior canine mobility.
Virbac welcomes Laura Watenpool, Vice President of Sales
The North American affiliate is pleased to announce that Laura Watenpool will join Virbac as the Vice President of Sales, effective Monday, October 23, 2023. In addition to her industry and leadership experience, Laura is a salesforce excellence champion. She brings these critical components to our commercial and leadership teams in alignment with the North American business strategy.
Virbac welcomes Mark Champ, Vice President of Marketing
10/05/2023
The North American affiliate announces Mark Champ will join the Executive Leadership Team, effective October 9, 2023. As Vice President of Marketing, Mark will develop and drive a multi-channel marketing strategy, blending our regional dynamics with the global mission of providing innovative products to those who care for animals every day.
